DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Sangamo Biosciences, Inc. (NASDAQ: SGMO)

5.66 -0.31 (-5.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGMO $5.66 -5.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.96
Previous Close $5.97
Daily Range $5.60 - $5.96
52-Week Range $5.30 - $19.25
Market Cap $396.5M
P/E Ratio -13.57
Dividend (Yield) $0.00 (0.0%)
Volume 1,139,493
Average Daily Volume 1,082,143
Current FY EPS -$0.60

Sector

Healthcare

Industry

Drug Makers

Sangamo Biosciences, Inc. (SGMO) Description

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes. Website: http://www.sangamo.com/

News & Commentary

Vertex Pharmaceuticals Incorporated Moved 16% Higher in October -- Here's Why

A great-looking third-quarter report sends shares of the cystic fibrosis leader higher.

Sangamo Biosciences (SGMO) Worth a Look: Stock Up 9.2%

Every Biotech Catalyst Wedbush Is Watching In 2016

Sangamo Biosciences (SGMO) Shares March Higher, Can It Continue?

Wedbush Offers Probabilities For Upcoming Catalysts In Emerging Pharmas

Sangamo BioSciences (SGMO) Is Strong On High Volume Today

Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, Firs

Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B

Trade-Ideas: Sangamo BioSciences (SGMO) Is Today's Strong On High Relative Volume Stock

Why Sangamo BioSciences Shares Rose 26% in October

A better-than-expected third-quarter earnings report sends shares of the beaten-down biotech higher.

Vertex Pharmaceuticals' $2.6 Billion Bet on CRISPR

CRISPR-Cas9 gene editing may be a huge breakthrough, but the odds are long and the field is crowded.

See More SGMO News...

SGMO's Top Competitors

SGMO $5.66 (-5.19%)
Current stock: SGMO
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
BIIB $263.86 (-3.44%)
Current stock: BIIB